Astrana Health
ASTH
172 hedge funds and large institutions have $935M invested in Astrana Health in 2024 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 64 increasing their positions, 48 reducing their positions, and 15 closing their positions.
4,812% more call options, than puts
Call options by funds: $26.3M | Put options by funds: $535K
100% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 15
33% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 48
8% more funds holding
Funds holding: 159 → 172 (+13)
0.06% more ownership
Funds ownership: 41.06% → 41.12% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $955M → $935M (-$20.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$9.53M |
| 2 |
FMI
F/M Investments
Washington,
District of Columbia
|
+$8.07M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.59M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.11M |
| 5 |
Diamond Hill Capital Management
Columbus,
Ohio
|
+$4.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$13.6M |
| 2 |
BlackRock
New York
|
-$5.99M |
| 3 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
-$1.78M |
| 4 |
TPSF
Texas Permanent School Fund
Austin,
Texas
|
-$1.55M |
| 5 |
Morgan Stanley
New York
|
-$1.31M |
ASTH Hedge Fund Activity: Q2 2024 in Review
172 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q2 2024, worth a combined $935M — down 2.2% from $955M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new ASTH positions and 15 closed out — a net gain of 15 holders — while 64 added to existing stakes and 48 trimmed.
The largest buyer was Bellevue Group, adding an estimated $9.53M. The largest seller was Vanguard Group, cutting an estimated $13.6M.
- 172 institutional investors held Astrana Health (ASTH) as of Q2 2024, up from 159 in Q1 2024.
- Funds reported $935M of Astrana Health stock for Q2 2024, down 2.2% quarter-over-quarter.
- 30 funds opened new Astrana Health positions in Q2 2024 and 15 closed out, a net change of +15 holders.
- The largest Astrana Health buyer in Q2 2024 was Bellevue Group, an estimated $9.53M added.
- The largest Astrana Health seller in Q2 2024 was Vanguard Group, an estimated $13.6M sold.
Based on aggregated 13F filings for Q2 2024.